CHENGDU,China,Jan. 6,2025-- Technoderma Medicines,Inc. ("the Company"),a clinical stage biopharmaceutical company,is pleased to report the Company has completed its Phase 2a clinical trial (
BusinessJan 8, 2025Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody,will be the lead clinical program following the Company\'s portfolio prioritization
BusinessJan 8, 2025Guide: Seizing Investment Opportunities in Hong Kong,Lead the Future of the Food and Beverage Industry
BusinessJan 8, 2025-Energy U Limited,Subsidiary of U Power,Forms Joint Venture to Deploy Battery Swapping Solutions- SHANGHAI,Jan. 6,2025-- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power")
BusinessJan 8, 2025ANAHEIM,Calif.,Jan. 7,2025--In a groundbreaking move set to transform the metal cutting industry,OMTech proudly introduces its latest innovations: the FC-22 and the FC-22C Fiber Laser Cutters. These c
BusinessJan 8, 2025English Morning News: Your Source for Regional News and Corporate
© English Morning News
Privacy Policy